Stage &or prognostic factors section:-:Pt: Patient:Set:NAACCR v.12

Preferred Label : Stage &or prognostic factors section:-:Pt: Patient:Set:NAACCR v.12;

LOINC status : ACTIVE;

LOINC long common name : Stage/prognostic factors section Set NAACCR v.12;

LOINC short name : Stage/prognost fact section NAACCR v.12;

Détails

Origin ID

60508-9;

UMLS CUI

C2970300;

Has component
- Stage [LOINC component]
- Stage/prognostic factors section [LOINC component]
Has method
- NAACCR [LOINC method]
- NAACCR v.12 [LOINC method]
Has scale
- Set [LOINC scale]
Has system
- Patient [LOINC System]
- ^Patient [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Panel of LOINC codes
- Coding system used:Prid:Pt:Cancer.XXX pediatric staging:Nom: [LOINC code]
- Collaborative staging lymph nodes:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging metastasis at diagnosis - bone involvement:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging metastasis at diagnosis - brain involvement:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging metastasis at diagnosis - liver involvement:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging metastasis at diagnosis - lung involvement:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging metastasis at diagnosis:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging metastasis evaluation:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging post treatment extension:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging post treatment lymph nodes:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging post treatment metastasis at diagnosis:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging post treatment tumor size:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging pre treatment extension:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging pre treatment lymph nodes:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging pre treatment metastasis at diagnosis:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging pre treatment regional nodes evaluation:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging pre treatment tumor size and extension evaluation:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging pre treatment tumor size:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging regional nodes evaluation:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 10:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 11:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 12:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 13:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 14:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 15:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 16:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 17:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 18:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 19:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 1:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 21:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 22:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 23:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 24:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 25:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 2:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 3:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 4:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 5:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 6:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 7:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 8:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging site-specific factor 9:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging tumor size extension evaluation:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging version.current:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging version.first:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Collaborative staging version.latest:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Comorbidities and complications 10:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 1:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 2:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 3:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 4:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 5:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 6:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 7:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 8:Prid:Pt:^Patient:Nom: [LOINC code]
- Comorbidities and complications 9:Prid:Pt:^Patient:Nom: [LOINC code]
- Derived American Joint Committee on Cancer M descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer M:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer N descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer N:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer T descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer T:Prid:Pt:Cancer.XXX:Nom:Derived [LOINC code]
- Derived American Joint Committee on Cancer conversion method:Arb:Pt:Cancer.XXX:Ord: [LOINC code]
- Derived American Joint Committee on Cancer stage group:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 M descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 M:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 N descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 N:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 T descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 T:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived American Joint Committee on Cancer-7 stage group:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived SEER summary stage 1977 conversion method:Arb:Pt:Cancer.XXX:Ord: [LOINC code]
- Derived SEER summary stage 1977:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived SEER summary stage 2000 conversion method:Arb:Pt:Cancer.XXX:Ord: [LOINC code]
- Derived SEER summary stage 2000:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived post treatment-7 M:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived post treatment-7 N:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived post treatment-7 T:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived post treatment-7 stage group:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 M descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 M:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 N descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 N:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 T descriptor:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 T:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Derived pre treatment-7 stage group:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Descriptor.clinical:Find:Pt:Cancer.XXX:Nar: [LOINC code]
- Descriptor.pathology:Find:Pt:Cancer.XXX:Nar: [LOINC code]
- Distant metastases.clinical:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- Distant metastases.pathology:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- Extension.collaborative staging:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Extension:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Extent of disease.NAACCR.old 13 digit:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Extent of disease.NAACCR.old 2 digit:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Extent of disease.NAACCR.old 4 digit:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Extent of disease:Type:Pt:Prostate cancer.XXX:Nom: [LOINC code]
- Flag for Derived neoadjuvant therapy not populated:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- ICD revision comorbidities:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Lymph node involvement:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Lymph-vascular invasion:Prid:Pt:Cancer specimen:Nom: [LOINC code]
- Pediatric cancer stager:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Pediatric stage:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Primary tumor.clinical:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- Primary tumor.pathology:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Regional lymph nodes examined:Num:Pt:Specimen:Qn: [LOINC code]
- Regional lymph nodes positive:Num:Pt:Specimen:Qn: [LOINC code]
- Regional lymph nodes.clinical:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- Regional lymph nodes.pathology:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER site-specific fact 1:ID:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER site-specific fact 2:ID:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER site-specific fact 3:ID:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER site-specific fact 4:ID:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER site-specific fact 5:ID:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER site-specific fact 6:ID:Pt:Cancer.XXX:Nom: [LOINC code]
- SEER summary stage 1977:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Scope of regional lymph node surgery at this facility 98-02:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Size:Len:Pt:Tumor:Qn: [LOINC code]
- Stage group.clinical:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- Stage group.pathology:Class:Pt:Cancer.XXX:Nom: [LOINC code]
- Stage.summary abbreviated at Dx:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Stage.summary at Dx 2000 revised:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Stager.clinical:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Stager.pathology:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02:Prid:Pt:Cancer.XXX:Nom: [LOINC code]
- Tumor marker:Type:Pt:Cancer.XXX:Nom: [LOINC code]
- Tumor size.collaborative staging:Len:Pt:Tumor:Qn: [LOINC code]
- Version used:ID:Pt:TNM classification:Nom: [LOINC code]
- Version used:Type:Pt:Extent of disease coding system:Nom: [LOINC code]
Part of panel
- North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel:-:Pt:^Patient:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients